SCHEMBL20230569

SCHEMBL20230569

CC1(C)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2Oc2cc(N3c4ccccc4C(C)(C)c4ccccc43)ccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.33
USP2 O75604 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
ALOX15 P16050 2/20 0.32
CYP2C19 P33261 2/20 0.32
HSD17B10 Q99714 2/20 0.32
CLK4 Q9HAZ1 2/20 0.32
LMNA P02545 1/20 0.32
CYP2C9 P11712 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MEN1 O00255 4/20 0.31
KMT2A Q03164 4/20 0.31
MAPT P10636 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
NPC1 O15118 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20230691 0.97 POLB (0.32) POLBUSP2CYP1A2CYP3A4CYP2D6
SCHEMBL20230690 0.97 POLB (0.33) POLBADORA2AADORA1L3MBTL1MEN1
SCHEMBL20230572 0.94 USP2 (0.32) POLBUSP2CYP1A2CYP3A4CYP2D6
SCHEMBL20230570 0.94 USP2 (0.33) POLBUSP2CYP1A2CYP3A4CYP2D6
SCHEMBL20230744 0.93 MEN1 (0.35) POLBUSP2CYP2C19HSD17B10LMNA
SCHEMBL20230624 0.93 HPSE (0.33) USP2CYP1A2CYP3A4CYP2D6ALOX15
SCHEMBL20230696 0.93 ADORA2A (0.32) POLBUSP2CYP1A2CYP3A4CYP2D6
SCHEMBL20230605 0.93 POLB (0.35) POLBUSP2CYP1A2CYP3A4CYP2D6
SCHEMBL22871841 0.92 POLB (0.31) POLB
SCHEMBL20230745 0.92 MEN1 (0.37) POLBCYP2C19HSD17B10LMNAADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CCNT1 POLB 1174/4885USP2 3860/4885CYP1A2 1512/4885
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CCNT1 POLB 1174/4885USP2 3860/4885CYP1A2 1512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.